Company: HMDCF
Filing Date: 2025-03-19
Form Type: 20-F
Source: 0001410578-25-000377
Chunk: 645

Company: HUTCHMED (China) Ltd
Filing Date: 2025-03-19
Form: 20-F
Item: Item 16K
Chunk 645
---
49,753  
  Net income/(loss)                                                                                               38,170          101,094       ( 360,386)  
  Less: Net income attributable to non-controlling interests                                                      ( 441)           ( 314)           ( 449)  
  Net income/(loss) attributable to the Company                                                                   37,729          100,780       ( 360,835)  
  Earnings/(losses) per share attributable to the Company (US$ per share)                                                                                   
  — basic                                                                                25                         0.04             0.12          ( 0.43)  
  — diluted                                                                              25                         0.04             0.12          ( 0.43)  
  Number of shares used in per share calculation                                                                                                            
  — basic                                                                                25                  855,351,683      849,654,296      847,143,540  
  — diluted                                                                              25                  872,829,129      869,196,348      847,143,540  

The accompanying notes are an integral part of these consolidated financial statements.

F-6

Table of Contents

HUTCHMED (CHINA) LIMITED

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS)

(IN US$’000)

                                                                                   Year Ended December 31,                                
                                                                                                      2024          2023            2022  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Net income/(loss)                                                                                 38,170       101,094      ( 360,386)  
  Other comprehensive loss                                                                                                                
  Foreign currency translation loss                                                               ( 3,753)      ( 6,592)        ( 8,469)  
  Total comprehensive income/(loss)                                                                 34,417        94,502      ( 368,855)  
  Less: Comprehensive (income)/loss attributable to non-controlling interests                       ( 110)            39             545  
  Total comprehensive income/(loss) attributable to the Company                                     34,307        94,541      ( 368,310)  

The accompanying notes are an integral part of these consolidated financial statements.

F-7

Table of Contents

HUTCHMED (CHINA) LIMITED

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(IN US$’000, EXCEPT SHARE